About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

view more

 

CRO

  • check

    Needs Discuss

  • check

    Quote and Ordar

  • check

    Timetable Schedule

  • check

    Report Launch

  • done

    Case Closed

view more

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

 

2024062014462755

 

麥德凱生科參加2024年全球生物醫學工程年會

 

聚焦技術創新,共同推動醫工領域國際合作與發展

 

 

2024年11月1日至3日 — 麥德凱生科將積極參與於國立成功大學舉辦的2024年全球生物醫學工程年會(GCBME),此次會議同時涵蓋台灣生物醫學工程科技研討會、台灣生物力學學會年度學術研討會,以及國科會醫工學門成果發表會。

 

此次年會將吸引來自台灣及全球各地的學者、醫師、臨床工程師、學生及業界專家與會,預估超過1,000人參加,共同推動醫工領域的創新與國際合作,提升台灣在全球生物醫學工程領域的影響力。

 

 

多元討論議題,探索生醫工程的未來
本次大會涵蓋六大研討會主題,深入探討生物醫學技術的最新研究與應用:
Group 1:生物力學 (Biomechanics)
Group 2:生醫電子及生醫光電子 (Biomedical Electronics + Biomedical Optoelectronics)
Group 3:生醫資訊與醫學影像 (Biomedical Informatics + Biomedical Imaging)
Group 4:生醫感測 (Biomedical Sensing)
Group 5:智慧醫療、復健輔具與創新創業 (Smart Healthcare + Rehabilitation Aids + Medical Device Innovation And Commercialization)
Group 6:生醫材料與奈米醫學 (Biomaterials + Nanomedicine)

 

國際交流與合作平台
此次年會集結全球頂尖專家,特設多場專題演講及學術報告,促進國際間的跨領域交流。會議期間,麥德凱生科也將積極參與產學交流活動,將展示針對產品的臨床前試驗至臨床的一條龍服務整合,尋求新合作夥伴。

 

推動台灣成為生醫創新重鎮
透過本次研討會,台灣將再次展現其在生物醫學工程領域的卓越成就。會議期間也將展示國科會醫工學門的最新研究成果,加速技術轉移及產業應用,為台灣在全球生醫產業中的地位奠定更堅實的基礎。

 


活動資訊

活動地點: 國立成功大學
活動日期: 2024年11月1日至3日